Moss B - Search Results

1

Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.

Quinn KM, Da Costa A, Yamamoto A, Berry D, Lindsay RW, Darrah PA, Wang L, Cheng C, Kong WP, Gall JG, Nicosia A, Folgori A, Colloca S, Cortese R, Gostick E, Price DA, Gomez CE, Esteban M, Wyatt LS, Moss B, Morgan C, Roederer M, Bailer RT, Nabel GJ, Koup RA, Seder RA. Quinn KM, et al. Among authors: moss b. J Immunol. 2013 Mar 15;190(6):2720-35. doi: 10.4049/jimmunol.1202861. Epub 2013 Feb 6. J Immunol. 2013. PMID: 23390298 Free PMC article.

2

Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.

Koenig S, Fuerst TR, Wood LV, Woods RM, Suzich JA, Jones GM, de la Cruz VF, Davey RT Jr, Venkatesan S, Moss B, et al. Koenig S, et al. Among authors: moss b. J Immunol. 1990 Jul 1;145(1):127-35. J Immunol. 1990. PMID: 1694201

3

Recombinant DNA virus vectors for vaccination.

Moss B. Moss B. Semin Immunol. 1990 Sep;2(5):317-27. Semin Immunol. 1990. PMID: 2134016 Review.

4

Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.

Lusso P, Markham PD, Ranki A, Earl P, Moss B, Dorner F, Gallo RC, Krohn KJ. Lusso P, et al. Among authors: moss b. J Immunol. 1988 Oct 1;141(7):2467-73. J Immunol. 1988. PMID: 3262661

5

Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Wyatt LS, Moss B, Rozenblatt S. Wyatt LS, et al. Among authors: moss b. Virology. 1995 Jun 20;210(1):202-5. doi: 10.1006/viro.1995.1332. Virology. 1995. PMID: 7793072 Free article.

6

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.

Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B. Sutter G, et al. Among authors: moss b. Vaccine. 1994 Aug;12(11):1032-40. doi: 10.1016/0264-410x(94)90341-7. Vaccine. 1994. PMID: 7975844

7

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP. Rao JB, et al. Among authors: moss b. J Immunol. 1996 May 1;156(9):3357-65. J Immunol. 1996. PMID: 8617961 Free PMC article.

8

Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Bender BS, Rowe CA, Taylor SF, Wyatt LS, Moss B, Small PA Jr. Bender BS, et al. Among authors: moss b. J Virol. 1996 Sep;70(9):6418-24. doi: 10.1128/JVI.70.9.6418-6424.1996. J Virol. 1996. PMID: 8709274 Free PMC article.

9

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.

Moss B, Carroll MW, Wyatt LS, Bennink JR, Hirsch VM, Goldstein S, Elkins WR, Fuerst TR, Lifson JD, Piatak M, Restifo NP, Overwijk W, Chamberlain R, Rosenberg SA, Sutter G. Moss B, et al. Adv Exp Med Biol. 1996;397:7-13. doi: 10.1007/978-1-4899-1382-1_2. Adv Exp Med Biol. 1996. PMID: 8718576 Free PMC article. Review.

10

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.

Wyatt LS, Shors ST, Murphy BR, Moss B. Wyatt LS, et al. Among authors: moss b. Vaccine. 1996 Oct;14(15):1451-8. doi: 10.1016/s0264-410x(96)00072-2. Vaccine. 1996. PMID: 8994321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,111 results

Search Page

Filters